Role of decentralized clinical trials in cancer drug development: Results from a survey of oncologists and patients.

de Las Heras, Begoña; Daehnke, Adam; Saini, Kamal S; Harris, Melissa; Morrison, Kenneth; Aguilo, Ariel; Chico, Isagani; Vidal, Laura; Marcus, Robin

de Las Heras, Begoña; Daehnke, Adam; Saini, Kamal S; Harris, Melissa; Morrison, Kenneth; Aguilo, Ariel; Chico, Isagani; Vidal, Laura; Marcus, Robin.

Afiliación

de Las Heras B; Labcorp Drug Development Inc., Burlington, North Carolina, USA.
Daehnke A; Madrid Medical Doctors Association, Spain.
Saini KS; Labcorp Drug Development Inc., Burlington, North Carolina, USA.
Harris M; Labcorp Drug Development Inc., Burlington, North Carolina, USA.
Morrison K; Labcorp Drug Development Inc., Burlington, North Carolina, USA.
Aguilo A; Labcorp Drug Development Inc., Burlington, North Carolina, USA.
Chico I; Labcorp Drug Development Inc., Burlington, North Carolina, USA.
Vidal L; Labcorp Drug Development Inc., Burlington, North Carolina, USA.
Marcus R; Labcorp Drug Development Inc., Burlington, North Carolina, USA.

Digit Health ; 8: 20552076221099997, 2022.

Article en En | MEDLINE | ID: mdl-35646380

Palabras clave

COVID-19 pandemic; Decentralized clinical trials; cancer; hybrid; oncology; patient centricity; remote clinical trial; survey; tele-oncology; virtual

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Aspecto: Patient_preference Idioma: En Revista: Digit Health Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google